Driehaus Capital Management LLC Kiniksa Pharmaceuticals, Ltd. Transaction History
Driehaus Capital Management LLC
- $9.13 Billion
- Q1 2024
A detailed history of Driehaus Capital Management LLC transactions in Kiniksa Pharmaceuticals, Ltd. stock. As of the latest transaction made, Driehaus Capital Management LLC holds 622,540 shares of KNSA stock, worth $12.4 Million. This represents 0.13% of its overall portfolio holdings.
Number of Shares
622,540
Previous 661,715
5.92%
Holding current value
$12.4 Million
Previous $11.6 Million
5.82%
% of portfolio
0.13%
Previous 0.15%
Shares
3 transactions
Others Institutions Holding KNSA
# of Institutions
164Shares Held
40.6MCall Options Held
186KPut Options Held
157K-
Black Rock Inc. New York, NY4.19MShares$83.3 Million0.0% of portfolio
-
Fairmount Funds Management LLC Philadelphia, PA3.2MShares$63.6 Million10.07% of portfolio
-
Hhlr Advisors, Ltd. Grand Cayman, E93.14MShares$62.3 Million1.37% of portfolio
-
Vanguard Group Inc Valley Forge, PA2.98MShares$59.2 Million0.0% of portfolio
-
Baker Bros. Advisors LP New York, NY2.81MShares$55.8 Million0.7% of portfolio
About Kiniksa Pharmaceuticals, Ltd.
- Ticker KNSA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 34,470,400
- Market Cap $685M
- Description
- Kiniksa Pharmaceuticals, Ltd., a biopharmaceutical company, focuses on discovering, acquiring, developing, and commercializing therapeutic medicines for patients suffering from debilitating diseases with significant unmet medical needs worldwide. Its product candidates include ARCALYST, an interleukin-1alpha and interleukin-1beta, for the treatm...